Improvement of the Operative Outcome in Patients With Primary VEGF + Unifocal Breast Cancer or DCIS Through the Intraoperative Visualization of the Tumor Using Molecular Imaging and Bevacizumab-IRDye-800CW

Condition:   Breast Cancer Intervention:   Drug: Bevacizumab-IRDye800CW Sponsor:   Technische Universität München Withdrawn
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials